The Institute of Pharmaceutical Innovation

Tuesday 26th July, 2005 Incubator Manager at the Institute of Pharmaceutical Innovation

The incubator facility on the fourth floor of the IPI was constructed to assist and develop bioscience start-up companies in the Yorkshire and Humber region. In 2004 funding was obtained from a HEIF2 grant to support the appointment of an Incubator Manager for biosciences activity within the region.

Read more of "Incubator Manager at the Institute of Pharmaceutical Innovation"...

Tuesday 26th July, 2005 IPI appoints leading scientist

The University has appointed a leader in computational chemistry to head its cutting-edge research and software development programme in pharmaceutical materials science at the Institute of Pharmaceutical Innovation (IPI).

Dr John Kendrick, who obtained a degree in Chemistry and a PhD in theoretical chemistry at Manchester University, was appointed earlier this year. After postdoctoral experience at the Hahn Meitner Institute in Berlin and Daresbury Laboratories here in the UK, working on the simulation of ion molecule reactions and electron scattering by atoms and molecules, he took a position in the modelling team at ICI, Runcorn.

Read more of "IPI appoints leading scientist"...

Thursday 23rd June, 2005 IPI hosts West Yorkshire Business Incubator Network event

The Business Incubators aim to provide structured support to promising new businesses that are ‘starting up’; ranging from assessing the commercial potential of the enterprise to business mentoring.

The ultimate goal is to enable an incubator business to become a successful independent business, thereby helping to sustain Bradford and the region’s position as one of the fastest growing economic areas in the country.

Read more of "IPI hosts West Yorkshire Business Incubator Network event"...

Tuesday 21st June, 2005 IPI Commissions High Performance Computing and Visualisation Facilities

The University of Bradford’s Institute of Pharmaceutical Innovation has powerful computing and visualisation facilities to support its innovative programme of computational pharmaceutics.

The IPI, opened by Science Minister Lord Sainsbury in October 2003, uses the latest artificial intelligence and computer simulation technology together with advanced analytical techniques to research new methods for the development of better drugs.

IPI’s new computational suite includes a High Performance Linux Compute Cluster which has the power of almost 100 normal PCs found in our homes and offices.

Frank Leusen.IPI Senior Scientist Dr Frank Leusen (pictured right): “The state-of-the-art computational and visualisation facilities allow us to perform and analyse complex simulations in pharmaceutical development that we could previously only dream of. Not only will it allow us to significantly reduce the time it takes to simulate an experiment from, say, one year to four days, it will also enable us to extend the scale of an experiment to 100 times the size we have previously been used to.”

Read more of " IPI Commissions High Performance Computing and Visualisation Facilities"...